FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/02/2023
Voltar para busca
Dado oficial do USPTO
NORTHWAY DIAGNOSTIC CENTER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
07/02/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
29/10/2020
Data de registro
27/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/09/2022
Última transação
27/09/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
16
Localização do titular
LT
Examinador
LIEBL, ALEXANDRA
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "NORTHWAY" in dark blue, where the "O" is made up of 4 curved bands. The top left and lower right curved bands are orange, the top right and lower left smaller bands are dark blue. Below the letters "RTHWAY" in "NORTHWAY" is the wording "DIAGNOSTIC CENTER" in orange.
Titulares e representantes
Titulares
UAB "Northway turto valdymas"
Representantes
JOHN ZACCARIA NOTARO MICHALOS & ZACCARIA PC
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19
Classe 42
Scientific and technological services, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of manufacture processes for biotechnology products; technological consultation in the field of development of manufacturing processes for biotechnology products
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/01/2023
FIMP
FINAL DISPOSITION PROCESSED
18/01/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
27/09/2022
TMBN
TTAB RELEASE CASE TO TRADEMARKS
24/08/2022
OP.T
OPPOSITION TERMINATED NO. 999999
24/08/2022
OP.D
OPPOSITION DISMISSED NO. 999999
24/08/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
27/06/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/06/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/06/2022
RFNT
REFUSAL PROCESSED BY IB
06/12/2021
OP.I
OPPOSITION INSTITUTED NO. 999999
20/11/2021
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
08/11/2021
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
06/11/2021
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
05/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/10/2021
PUBO
PUBLISHED FOR OPPOSITION
26/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/09/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/09/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/09/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
20/09/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/09/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/09/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/09/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/07/2021
RFNT
REFUSAL PROCESSED BY IB
13/04/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/03/2021
RFRR
REFUSAL PROCESSED BY MPU
23/03/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/03/2021
CNRT
NON-FINAL ACTION WRITTEN
19/03/2021
DOCK
ASSIGNED TO EXAMINER
15/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
08/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
31/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NORTHWAY DIAGNOSTIC CENTER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.